门诊肺部医学中的新疗法
Laura Granados1, Mira John1, Jeffrey D Edelman2
1Department of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, USA.
The Medical clinics of North America
|July 31, 2024
概括
肺部疾病治疗的进步为喘,COPD和囊性纤维化提供了新的选择. 了解风险和益处是优化这些不断发展的疗法患者结果的关键.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 医学治疗学 医学治疗学
背景情况:
- 肺部疾病的治疗已经随着新的药物和设备的发展而发展.
- 对现有治疗方法的更好理解可以改善患者的护理.
- 在各种肺部疾病中,治疗风险和益处存在显著的变化.
研究的目的:
- 审查主要肺部疾病的一般治疗方法.
- 专注于新疗法选择的作用和应用.
- 为了解异质性肺部疾病的当前治疗策略提供了解.
主要方法:
- 关于呼吸系统医学近期进展的文献综述.
- 对治疗疗效和安全性概况的分析.
- 综合关于一般和新型治疗干预措施的信息.
主要成果:
- 对于各种肺部疾病,可提供扩展的治疗选择.
- 治疗方面的进步对喘,COPD,间歇性肺病,肺高血压和囊性纤维化等疾病的结果产生了积极的影响.
- 较新的疗法需要仔细考虑个体患者的需求和疾病特征.
结论:
- 对肺部疾病和治疗方法的全面了解至关重要.
- 定义新疗法的作用需要评估它们的风险和益处.
- 优化患者的治疗结果依赖于明智的选择和应用不断发展的治疗策略.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
192
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
192
Drugs Used in Lower Respiratory Disorders: Overview
386
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
386
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
165
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
165
COPD: Management Using Bronchodilators and Corticosteroids
193
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
193
Pulmonary Tuberculosis V
176
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
176


